Lexicon Pharmaceuticals | LXRX - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Abbott USD 178.41B 39.46B 2026-03
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.66B 257M 2026-03
Illumina USD 17.88B 2.74B 2026-03
Insmed USD 35.3B 1.82B 2026-03
J&J USD 579.15B 78.91B 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MannKind USD 757M 984M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Novartis USD 307.76B 15.54B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12